Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at care and outcomes for people with Treatment Resistant Depression or depression. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
This observational study is following people with Epilepsy, Depression, Anxiety, or Emotions to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Treatment Resistant Depression, Inflammation, or Overweight to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at care and outcomes for people with depression. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
This study is looking at evaluate an intervention for improving Science, Technology, Engineering, and Math (STEM) graduate student wellbeing for people with Depression, Anxiety, or Burnout, Student. Participants take part in a mental health workshop and complete follow-up assessments.
This observational study is following people with Depression in Adolescence or Suicide Prevention to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether a digital support tool can help people with Depression - depression. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether questionnaires and follow-up can help people with depression. Participants take part in the program and complete follow-up questionnaires or assessments.
This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at determine efficacy differences between ALTO-300 and placebo, used adjunctively to an antidepressant, related to patient characteristics for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing Lumateperone with placebo for people with depression. Participants receive Lumateperone or placebo and complete study visits and assessments.
This study is comparing Attention Bias Modification Training with Control for people with anxiety or depression. Participants receive Attention Bias Modification Training or Control and complete study visits and assessments.
This study is looking at investigate the safety and efficacy of dimethyltryptamine (DMT) in individuals with depression and healthy controls for people with Major Depression Disorder or Depression. Participants receive DMT-Medium Dose or placebo and complete study visits and assessments.
This study is looking at identify how enhanced allopregnanolone activity (via pregnenolone) affects behavior and neurobiology that may underlie perimenopausal depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with depression. Taking part may give some people access to NMRA-335140, but direct benefit is not guaranteed.
This study is looking at evaluate the efficacy of Ropanicant at two different dosage levels compared to placebo in patients with Major Depressive Disorder (depression) for people with depression. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group for people with Treatment Resistant Depression. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Depression, Treatment Resistant Depression, bipolarity, or Mental Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at care and outcomes for people with Depression or Suicide. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
This study is comparing ENCODE with Attention Control Group for people with Caregiver Stress Syndrome, Anxiety, or Depression. Participants receive ENCODE or Attention Control Group and complete study visits and assessments.
This observational study is following people with Depression, Anxiety to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.